Apimeds Pharmaceuticals US, Inc (APUS) | Bitcoin Treasury Stock
Apimeds Pharmaceuticals US, Inc
APUS
$3.09
(-4.92%)
Last update
07:59 PM UTC · Oct 22
·
AMEX
#44 Bitcoin Treasuries
Apimeds Pharmaceuticals US, Inc
APUS
#44 in Bitcoin Treasuries
$3.09
(-4.92%)
Last update
07:59 PM UTC · Oct 22, 2026
Market
Market Overview
Market Cap
$4,663,171
Shares Outstanding
50-Day Moving Average
$3.85
200-Day Moving Average
$11.32
Average Volume (20 Days)
7,111,573
Beta (5Y)
0.0
Price History
| Date | OPEN | HIGH | LOW | CLOSE | VWAP | VOLUME | %CHG | $CHG |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
About
Apimeds Pharmaceuticals US, Inc Company Overview
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) is a clinical-stage biopharmaceutical and digital asset company headquartered in Matawan, New Jersey. It is developing Apitox, a bee venom-based injectable therapy for pain and inflammation from knee osteoarthritis. In December 2025 it acquired MindWave Innovations Inc, which operates the MindWaveDAO blockchain ecosystem and is building Bitcoin treasury and yield infrastructure for institutions. The company held about 1,004.84 BTC as of June 30, 2026, along with NILA tokens and USDT.
Stock Exchange
AMEX
IPO Date
2025-05-09
Number of Employees
16
Headquarters
Matawan, New Jersey, US
Key Executives
Vinod Menon
Chief Executive Officer
News & Filings
Featured Posts
View all articlesPress Releases
No press releases found.
SEC Filings
| Form Type | Filed | Accepted | Source |
|---|
APUS Frequently Asked Questions
As of
June 30, 2026, Apimeds Pharmaceuticals US, Inc holds approximately
1,004.84
BTC
as part of its corporate Bitcoin treasury strategy. For more
comprehensive insights, you can track
APUS 's Bitcoin holdings on our
Bitcoin Treasuries
page.
The current stock price of Apimeds Pharmaceuticals US, Inc
(APUS) is
$3.09
as of
07:59 PM UTC · Oct 22, 2026 . For live stock updates and company rankings, view our
Bitcoin mining stocks by market cap
table.
The latest news for Apimeds Pharmaceuticals US, Inc
(APUS) includes
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
published on
May
5,
2026
. For more details and ongoing updates, visit the
APUS news
section.